Related Experiment Video

Updated: Mar 30, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.7K

Tumor suppressive effect of PARP1 and FOXO3A in gastric cancers and its clinical implications

See-Hyoung Park1,2, Kyu Yun Jang3, Min Jae Kim1,4

  • 1Department of Physiology, Ajou University School of Medicine, Suwon, Republic of Korea.

Oncotarget
|November 6, 2015
PubMed

Insights

Poly (ADP-ribose) polymerase 1 (PARP1) inhibition slows gastric cancer growth by causing cell cycle arrest. PARP1 and FOXO3A expression levels predict patient survival, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Poly (ADP-ribose) polymerase 1 (PARP1) is a potential chemotherapy target in various cancers.
  • Its specific mechanisms and impact on gastric cancer survival remain unclear.

Purpose of the Study:

  • To investigate the effects of PARP1 inhibition on gastric cancer cell growth.
  • To explore the role of PARP1 and FOXO3A in gastric cancer progression and patient outcomes.

Main Methods:

  • Gastric cancer cells were treated with PARP1 inhibitors (Olaparib or siRNA).
  • Cell growth, colony formation, and cell cycle progression were analyzed.
  • Tissue microarrays from 166 gastric cancer patients were used to assess PARP1 and FOXO3A expression.

Main Results:

  • PARP1 inhibition significantly reduced gastric cancer cell growth and colony formation.
  • Inhibition induced G2/M cell cycle arrest, not apoptosis.
  • Upregulation of FOXO3A expression was observed upon PARP1 inhibition.
  • PARP1 and FOXO3A expression levels correlated significantly with overall survival (OS) and relapse-free survival (RFS).
  • Combined PARP1/FOXO3A status provided a strong prediction of clinical outcomes, with PARP1+/FOXO3A- indicating the worst prognosis and PARP1-/FOXO3A+ the most favorable.

Conclusions:

  • PARP1 and FOXO3A are crucial in gastric cancer progression.
  • Targeting PARP1 and monitoring FOXO3A expression may offer therapeutic and diagnostic potential for gastric cancer.
Keywords:
FOXO3AG2/M arrestPARP1olaparibprognosis

More Related Videos

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.4K
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.9K

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.0K